A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
|Articles|April 6, 2023
Seen in the ED: Facial Pain and Swelling, Sour Mouth
Author(s)Brady Pregerson, MD
Advertisement
History of present illness. A man in his 50s presents to urgent care for 2 days of right facial swelling and pain. He denies any fever but does state he has a bad taste in his mouth.
Vital signs and physical examination. Vital signs are normal except for mild tachycardia. Examination is notable for facial swelling on the right. Dentition looks good.
Initial diagnostic testing
Labs: WBC = 14, BMP normal, CRP = 20
Imaging: CT scan is done. Two cuts are shown below.
What is the most likely diagnosis?
Advertisement
Related to this article
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
The FDA accepted Organon’s MIUDELLA supplemental application, but the proposed change, supporting data, and review timeline remain undisclosed.
Advertisement
Advertisement
Trending on Patient Care Online
1
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Clinical Inertia and Poor Measurement Technique Undermine BP Control
4
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
5